Zobrazeno 1 - 3
of 3
pro vyhledávání: '"direct oral anti- FXa anticoagulants"'
Autor:
Fanny Ofek, Dana Barchel, Nofar Perets, Tomer Ziv-Baran, Ahmad Mahajna, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, Maya Berlin, Matitiahu Berkovitch
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The
Externí odkaz:
https://doaj.org/article/bdf71e7c73564bd8ad25085f578c4a52
Autor:
Matitiahu Berkovitch, Maya Berlin, Dana Barchel, Ahmad Mahajna, Fanny Ofek, Tomer Ziv-Baran, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, Nofar Perets
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology
Frontiers in Pharmacology
Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2da08531298b86fa1eff6749900c323
https://www.frontiersin.org/article/10.3389/fphar.2019.01177/full
https://www.frontiersin.org/article/10.3389/fphar.2019.01177/full
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.